Share Price and Basic Stock Data
Last Updated: February 25, 2025, 5:17 am
PEG Ratio | 5.16 |
---|
Competitors of Gillette India Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Honasa Consumer Ltd | 7,254 Cr. | 223 | 547/197 | 106 | 35.5 | 0.00 % | 17.1 % | % | 10.0 |
Ambica Agarbathies Aroma & Industries Ltd | 47.3 Cr. | 27.5 | 37.0/23.2 | 17.8 | 60.6 | 0.00 % | 5.07 % | 3.65 % | 10.0 |
Ador Multi Products Ltd | 12.4 Cr. | 26.6 | 45.9/23.4 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
Kaya Ltd | 342 Cr. | 261 | 702/224 | 106 | 0.00 % | 80.4 % | % | 10.0 | |
Jyothy Labs Ltd | 12,434 Cr. | 339 | 596/332 | 33.4 | 51.4 | 1.03 % | 27.0 % | 21.2 % | 1.00 |
Industry Average | 67,688.64 Cr | 1,942.34 | 47.55 | 109.30 | 0.80% | 36.43% | 29.37% | 4.94 |
Quarterly Result
Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 436 | 573 | 563 | 567 | 553 | 620 | 619 | 619 | 619 | 668 | 639 | 681 | 645 |
Expenses | 384 | 448 | 449 | 435 | 441 | 484 | 493 | 485 | 476 | 531 | 484 | 520 | 471 |
Operating Profit | 52 | 125 | 114 | 132 | 112 | 136 | 126 | 134 | 144 | 137 | 156 | 160 | 175 |
OPM % | 12% | 22% | 20% | 23% | 20% | 22% | 20% | 22% | 23% | 20% | 24% | 24% | 27% |
Other Income | 3 | 3 | 2 | 1 | 2 | 3 | 3 | 12 | 5 | 9 | 7 | 6 | 5 |
Interest | 3 | 0 | 2 | 5 | 2 | 0 | 3 | 1 | 3 | 0 | 3 | 3 | 3 |
Depreciation | 15 | 16 | 16 | 18 | 19 | 18 | 19 | 22 | 22 | 20 | 21 | 21 | 21 |
Profit before tax | 38 | 112 | 97 | 110 | 92 | 120 | 106 | 123 | 124 | 125 | 139 | 143 | 155 |
Tax % | 27% | 27% | 27% | 37% | 27% | 28% | 30% | 16% | 26% | 26% | 25% | 31% | 25% |
Net Profit | 28 | 82 | 70 | 69 | 68 | 87 | 74 | 103 | 92 | 93 | 104 | 99 | 116 |
EPS in Rs | 8.45 | 25.14 | 21.64 | 21.27 | 20.74 | 26.63 | 22.85 | 31.52 | 28.16 | 28.45 | 31.90 | 30.41 | 35.59 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,220 | 1,424 | 1,662 | 1,875 | 1,755 | 1,733 | 1,677 | 1,862 | 1,679 | 1,982 | 2,256 | 2,477 | 2,546 |
Expenses | 1,112 | 1,290 | 1,589 | 1,684 | 1,448 | 1,348 | 1,290 | 1,478 | 1,319 | 1,522 | 1,773 | 1,937 | 1,976 |
Operating Profit | 108 | 134 | 73 | 191 | 306 | 385 | 387 | 384 | 360 | 460 | 483 | 540 | 570 |
OPM % | 9% | 9% | 4% | 10% | 17% | 22% | 23% | 21% | 21% | 23% | 21% | 22% | 22% |
Other Income | 33 | 36 | 38 | 68 | 50 | 34 | 8 | 11 | 11 | 32 | 7 | 22 | 32 |
Interest | 0 | 0 | 0 | 5 | 6 | 7 | 7 | 8 | 5 | 5 | 11 | 8 | 7 |
Depreciation | 24 | 31 | 33 | 39 | 30 | 38 | 42 | 48 | 51 | 58 | 68 | 81 | 84 |
Profit before tax | 117 | 138 | 78 | 215 | 320 | 374 | 345 | 339 | 314 | 429 | 411 | 473 | 511 |
Tax % | 35% | 37% | 34% | 26% | 33% | 32% | 34% | 25% | 27% | 28% | 30% | 25% | |
Net Profit | 76 | 87 | 51 | 158 | 214 | 253 | 229 | 253 | 230 | 310 | 289 | 356 | 391 |
EPS in Rs | 23.24 | 26.75 | 15.78 | 48.53 | 65.73 | 77.67 | 70.29 | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | 120.03 |
Dividend Payout % | 65% | 56% | 95% | 31% | 60% | 211% | 33% | 57% | 69% | 125% | 78% | 78% |
YoY Net Profit Growth
Year |
---|
YoY Net Profit Growth (%) |
Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 5% |
5 Years: | 7% |
3 Years: | 10% |
TTM: | 10% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 10% |
3 Years: | 10% |
TTM: | 21% |
Stock Price CAGR | |
---|---|
10 Years: | 7% |
5 Years: | 8% |
3 Years: | 18% |
1 Year: | 30% |
Return on Equity | |
---|---|
10 Years: | 34% |
5 Years: | 36% |
3 Years: | 39% |
Last Year: | 42% |
Last Updated: Unknown
Balance Sheet
Last Updated: February 12, 2025, 4:16 pm
Month | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
Reserves | 617 | 611 | 710 | 904 | 468 | 662 | 746 | 879 | 756 | 829 | 956 | 939 | 1,052 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Liabilities | 390 | 411 | 468 | 488 | 498 | 515 | 432 | 441 | 606 | 758 | 927 | 859 | 885 |
Total Liabilities | 1,039 | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,970 |
Fixed Assets | 170 | 173 | 156 | 178 | 214 | 264 | 300 | 296 | 310 | 363 | 389 | 347 | 344 |
CWIP | 30 | 61 | 63 | 88 | 63 | 40 | 25 | 21 | 72 | 65 | 32 | 26 | 35 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 839 | 821 | 991 | 1,158 | 721 | 904 | 886 | 1,034 | 1,013 | 1,191 | 1,494 | 1,458 | 1,591 |
Total Assets | 1,039 | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,970 |
Cash Flow
Month | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 108.00 | 134.00 | 73.00 | 191.00 | 306.00 | 385.00 | 387.00 | 384.00 | 360.00 | 460.00 | 483.00 | 540.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Jun 2013 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 24 | 20 | 23 | 23 | 27 | 38 | 36 | 41 | 36 | 43 | 47 | 38 |
Inventory Days | 131 | 104 | 87 | 104 | 103 | 105 | 104 | 136 | 152 | 130 | 127 | 131 |
Days Payable | 122 | 116 | 116 | 137 | 150 | 173 | 126 | 138 | 169 | 193 | 209 | 212 |
Cash Conversion Cycle | 33 | 9 | -6 | -10 | -19 | -30 | 15 | 40 | 19 | -20 | -35 | -43 |
Working Capital Days | 48 | 27 | 49 | -10 | -17 | -18 | 15 | 35 | 14 | -0 | -3 | -7 |
ROCE % | 22% | 12% | 35% | 39% | 54% | 60% | 48% | 38% | 51% | 51% | 52% | 58% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Aditya Birla Sun Life ELSS Tax Saver Fund | 464,089 | 2.04 | 305.64 | 94,494 | 2025-02-24 | 391.13% |
Aditya Birla Sun Life MNC Fund - Div | 194,572 | 3.57 | 128.14 | 94,494 | 2025-02-24 | 105.91% |
Aditya Birla Sun Life MNC Fund - Gr | 194,572 | 3.57 | 128.14 | 94,494 | 2025-02-24 | 105.91% |
Nippon India Multi Cap Fund | 190,000 | 0.49 | 125.13 | 94,494 | 2025-02-24 | 101.07% |
Nippon India Large Cap Fund | 165,000 | 0.51 | 108.67 | 94,494 | 2025-02-24 | 74.61% |
ICICI Prudential India Opportunities Fund | 127,095 | 0.52 | 83.7 | 94,494 | 2025-02-24 | 34.5% |
ICICI Prudential Smallcap Fund | 117,482 | 1.04 | 77.37 | 94,494 | 2025-02-24 | 24.33% |
ICICI Prudential FMCG Fund - Dividend | 100,459 | 4.44 | 66.16 | 94,494 | 2025-02-24 | 6.31% |
ICICI Prudential FMCG Fund - Growth | 100,459 | 4.44 | 66.16 | 94,494 | 2025-02-24 | 6.31% |
ICICI Prudential Bharat Consumption Fund | 94,494 | 2.82 | 62.23 | 94,494 | 2025-02-24 | 0% |
Key Financial Ratios
Month | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 126.35 | 109.15 | 88.79 | 95.25 | 70.64 |
Diluted EPS (Rs.) | 126.35 | 109.15 | 88.79 | 95.25 | 70.64 |
Cash EPS (Rs.) | 151.68 | 133.90 | 109.75 | 112.89 | 86.29 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 298.03 | 303.42 | 264.25 | 242.10 | 279.62 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 298.03 | 303.42 | 264.25 | 242.10 | 279.62 |
Dividend / Share (Rs.) | 130.00 | 85.00 | 69.00 | 119.00 | 49.00 |
Revenue From Operations / Share (Rs.) | 807.94 | 760.06 | 692.28 | 616.58 | 515.21 |
PBDIT / Share (Rs.) | 200.53 | 172.25 | 150.42 | 151.04 | 113.67 |
PBIT / Share (Rs.) | 175.17 | 147.49 | 129.44 | 133.39 | 98.01 |
PBT / Share (Rs.) | 172.52 | 145.10 | 126.21 | 131.78 | 96.34 |
Net Profit / Share (Rs.) | 126.33 | 109.14 | 88.78 | 95.24 | 70.63 |
PBDIT Margin (%) | 24.81 | 22.66 | 21.72 | 24.49 | 22.06 |
PBIT Margin (%) | 21.68 | 19.40 | 18.69 | 21.63 | 19.02 |
PBT Margin (%) | 21.35 | 19.09 | 18.23 | 21.37 | 18.69 |
Net Profit Margin (%) | 15.63 | 14.35 | 12.82 | 15.44 | 13.70 |
Return on Networth / Equity (%) | 42.38 | 35.96 | 33.59 | 39.33 | 25.25 |
Return on Capital Employeed (%) | 53.26 | 43.68 | 44.66 | 50.06 | 32.83 |
Return On Assets (%) | 22.48 | 18.56 | 17.98 | 22.24 | 17.02 |
Asset Turnover Ratio (%) | 1.41 | 1.41 | 1.50 | 1.46 | 1.31 |
Current Ratio (X) | 1.56 | 1.53 | 1.43 | 1.46 | 2.02 |
Quick Ratio (X) | 1.04 | 1.03 | 0.87 | 0.76 | 1.27 |
Inventory Turnover Ratio (X) | 1.68 | 1.73 | 1.60 | 1.48 | 0.72 |
Dividend Payout Ratio (NP) (%) | 106.84 | 65.04 | 77.71 | 138.57 | 35.38 |
Dividend Payout Ratio (CP) (%) | 88.98 | 53.01 | 62.85 | 116.91 | 28.96 |
Earning Retention Ratio (%) | -6.84 | 34.96 | 22.29 | -38.57 | 64.62 |
Cash Earning Retention Ratio (%) | 11.02 | 46.99 | 37.15 | -16.91 | 71.04 |
Interest Coverage Ratio (X) | 75.73 | 72.25 | 46.55 | 93.76 | 68.10 |
Interest Coverage Ratio (Post Tax) (X) | 48.71 | 46.78 | 28.48 | 60.12 | 43.31 |
Enterprise Value (Cr.) | 23131.91 | 16107.66 | 16033.26 | 18343.17 | 15994.41 |
EV / Net Operating Revenue (X) | 8.79 | 6.50 | 7.11 | 9.13 | 9.53 |
EV / EBITDA (X) | 35.40 | 28.69 | 32.71 | 37.27 | 43.17 |
MarketCap / Net Operating Revenue (X) | 8.97 | 6.69 | 7.24 | 9.21 | 9.66 |
Retention Ratios (%) | -6.84 | 34.95 | 22.28 | -38.57 | 64.61 |
Price / BV (X) | 24.31 | 16.75 | 18.96 | 23.46 | 17.81 |
Price / Net Operating Revenue (X) | 8.97 | 6.69 | 7.24 | 9.21 | 9.66 |
EarningsYield | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Gillette India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Jun 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Jun 24, the value is 126.35. This value is within the healthy range. It has increased from 109.15 (Jun 23) to 126.35, marking an increase of 17.20.
- For Diluted EPS (Rs.), as of Jun 24, the value is 126.35. This value is within the healthy range. It has increased from 109.15 (Jun 23) to 126.35, marking an increase of 17.20.
- For Cash EPS (Rs.), as of Jun 24, the value is 151.68. This value is within the healthy range. It has increased from 133.90 (Jun 23) to 151.68, marking an increase of 17.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 298.03. It has decreased from 303.42 (Jun 23) to 298.03, marking a decrease of 5.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Jun 24, the value is 298.03. It has decreased from 303.42 (Jun 23) to 298.03, marking a decrease of 5.39.
- For Dividend / Share (Rs.), as of Jun 24, the value is 130.00. This value exceeds the healthy maximum of 3. It has increased from 85.00 (Jun 23) to 130.00, marking an increase of 45.00.
- For Revenue From Operations / Share (Rs.), as of Jun 24, the value is 807.94. It has increased from 760.06 (Jun 23) to 807.94, marking an increase of 47.88.
- For PBDIT / Share (Rs.), as of Jun 24, the value is 200.53. This value is within the healthy range. It has increased from 172.25 (Jun 23) to 200.53, marking an increase of 28.28.
- For PBIT / Share (Rs.), as of Jun 24, the value is 175.17. This value is within the healthy range. It has increased from 147.49 (Jun 23) to 175.17, marking an increase of 27.68.
- For PBT / Share (Rs.), as of Jun 24, the value is 172.52. This value is within the healthy range. It has increased from 145.10 (Jun 23) to 172.52, marking an increase of 27.42.
- For Net Profit / Share (Rs.), as of Jun 24, the value is 126.33. This value is within the healthy range. It has increased from 109.14 (Jun 23) to 126.33, marking an increase of 17.19.
- For PBDIT Margin (%), as of Jun 24, the value is 24.81. This value is within the healthy range. It has increased from 22.66 (Jun 23) to 24.81, marking an increase of 2.15.
- For PBIT Margin (%), as of Jun 24, the value is 21.68. This value exceeds the healthy maximum of 20. It has increased from 19.40 (Jun 23) to 21.68, marking an increase of 2.28.
- For PBT Margin (%), as of Jun 24, the value is 21.35. This value is within the healthy range. It has increased from 19.09 (Jun 23) to 21.35, marking an increase of 2.26.
- For Net Profit Margin (%), as of Jun 24, the value is 15.63. This value exceeds the healthy maximum of 10. It has increased from 14.35 (Jun 23) to 15.63, marking an increase of 1.28.
- For Return on Networth / Equity (%), as of Jun 24, the value is 42.38. This value is within the healthy range. It has increased from 35.96 (Jun 23) to 42.38, marking an increase of 6.42.
- For Return on Capital Employeed (%), as of Jun 24, the value is 53.26. This value is within the healthy range. It has increased from 43.68 (Jun 23) to 53.26, marking an increase of 9.58.
- For Return On Assets (%), as of Jun 24, the value is 22.48. This value is within the healthy range. It has increased from 18.56 (Jun 23) to 22.48, marking an increase of 3.92.
- For Asset Turnover Ratio (%), as of Jun 24, the value is 1.41. There is no change compared to the previous period (Jun 23) which recorded 1.41.
- For Current Ratio (X), as of Jun 24, the value is 1.56. This value is within the healthy range. It has increased from 1.53 (Jun 23) to 1.56, marking an increase of 0.03.
- For Quick Ratio (X), as of Jun 24, the value is 1.04. This value is within the healthy range. It has increased from 1.03 (Jun 23) to 1.04, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Jun 24, the value is 1.68. This value is below the healthy minimum of 4. It has decreased from 1.73 (Jun 23) to 1.68, marking a decrease of 0.05.
- For Dividend Payout Ratio (NP) (%), as of Jun 24, the value is 106.84. This value exceeds the healthy maximum of 50. It has increased from 65.04 (Jun 23) to 106.84, marking an increase of 41.80.
- For Dividend Payout Ratio (CP) (%), as of Jun 24, the value is 88.98. This value exceeds the healthy maximum of 50. It has increased from 53.01 (Jun 23) to 88.98, marking an increase of 35.97.
- For Earning Retention Ratio (%), as of Jun 24, the value is -6.84. This value is below the healthy minimum of 40. It has decreased from 34.96 (Jun 23) to -6.84, marking a decrease of 41.80.
- For Cash Earning Retention Ratio (%), as of Jun 24, the value is 11.02. This value is below the healthy minimum of 40. It has decreased from 46.99 (Jun 23) to 11.02, marking a decrease of 35.97.
- For Interest Coverage Ratio (X), as of Jun 24, the value is 75.73. This value is within the healthy range. It has increased from 72.25 (Jun 23) to 75.73, marking an increase of 3.48.
- For Interest Coverage Ratio (Post Tax) (X), as of Jun 24, the value is 48.71. This value is within the healthy range. It has increased from 46.78 (Jun 23) to 48.71, marking an increase of 1.93.
- For Enterprise Value (Cr.), as of Jun 24, the value is 23,131.91. It has increased from 16,107.66 (Jun 23) to 23,131.91, marking an increase of 7,024.25.
- For EV / Net Operating Revenue (X), as of Jun 24, the value is 8.79. This value exceeds the healthy maximum of 3. It has increased from 6.50 (Jun 23) to 8.79, marking an increase of 2.29.
- For EV / EBITDA (X), as of Jun 24, the value is 35.40. This value exceeds the healthy maximum of 15. It has increased from 28.69 (Jun 23) to 35.40, marking an increase of 6.71.
- For MarketCap / Net Operating Revenue (X), as of Jun 24, the value is 8.97. This value exceeds the healthy maximum of 3. It has increased from 6.69 (Jun 23) to 8.97, marking an increase of 2.28.
- For Retention Ratios (%), as of Jun 24, the value is -6.84. This value is below the healthy minimum of 30. It has decreased from 34.95 (Jun 23) to -6.84, marking a decrease of 41.79.
- For Price / BV (X), as of Jun 24, the value is 24.31. This value exceeds the healthy maximum of 3. It has increased from 16.75 (Jun 23) to 24.31, marking an increase of 7.56.
- For Price / Net Operating Revenue (X), as of Jun 24, the value is 8.97. This value exceeds the healthy maximum of 3. It has increased from 6.69 (Jun 23) to 8.97, marking an increase of 2.28.
- For EarningsYield, as of Jun 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Jun 23) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillette India Ltd:
- Net Profit Margin: 15.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 53.26% (Industry Average ROCE: 36.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 42.38% (Industry Average ROE: 25.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 48.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.04
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.7 (Industry average Stock P/E: 38.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.63%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Personal Care | P&G Plaza, Mumbai Maharashtra 400099 | investorgil.im@pg.com https://www.gillette.co.in |
Management | |
---|---|
Name | Position Held |
Ms. Anjuly Chib Duggal | Chairman & Ind.Director |
Mr. Kumar Venkatasubramanian | Managing Director |
Ms. Srividya Srinivasan | Executive Director & CFO |
Mr. Srinivas Maruthi Patnam | Executive Director |
Mr. Pramod Agarwal | Non Executive Director |
Mr. Sanjay Asher | Independent Director |
Mr. C P Gurnani | Independent Director |
FAQ
What is the latest intrinsic value of Gillette India Ltd?
Let's break down Gillette India Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 25 February 2025:
- Calculated Fair Value: ₹6583.10
- Current Market Price: ₹8,392.00
- Variance: 21.56% lower
This suggests Gillette India Ltd is currently overvalued by 21.56%. For context:
- Market Cap: 27,351 Cr.
- 52-Week Range: 10,699/6,191
- Reserves (Dec 2024): ₹1,052 Cr
- Liabilities: 1,970 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of Gillette India Ltd?
The Market Cap of Gillette India Ltd is 27,351 Cr..
What is the current Stock Price of Gillette India Ltd as on 25 February 2025?
The current stock price of Gillette India Ltd as on 25 February 2025 is ₹8,392.
What is the High / Low of Gillette India Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Gillette India Ltd stocks is 10,699/6,191.
What is the Stock P/E of Gillette India Ltd?
The Stock P/E of Gillette India Ltd is 57.7.
What is the Book Value of Gillette India Ltd?
The Book Value of Gillette India Ltd is 333.
What is the Dividend Yield of Gillette India Ltd?
The Dividend Yield of Gillette India Ltd is 0.77 %.
What is the ROCE of Gillette India Ltd?
The ROCE of Gillette India Ltd is 58.9 %.
What is the ROE of Gillette India Ltd?
The ROE of Gillette India Ltd is 42.5 %.
What is the Face Value of Gillette India Ltd?
The Face Value of Gillette India Ltd is 10.0.